Stevanato Group SpA
Closed
SectorHealthcare
22.46 1.13
Overview
Share price change
24h
Min
22.41
Max
22.56
Income | -1.1M 38M |
|---|---|
Sales | 28M 302M |
P/E Sector Avg | 37.964 57.371 |
EPS | 0.16 |
Profit margin | 12.622 |
Employees | 6,010 |
EBITDA | -25M 40M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +1.77% upside |
Next Earnings | 5 Nov 2026 |
|---|
Market Cap | 186M 5.8B |
|---|---|
Previous open | 21.33 |
Previous close | 22.46 |
Stevanato Group SpA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Stevanato Group SpA Forecast
Price Target
By TipRanks
1.77% upside
12 Months Forecast
Average 23 USD 1.77%
High 26 USD
Low 20 USD
Based on 6 Wall Street analysts offering 12 month price targets forStevanato Group SpA - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.